Research studies

Derbyshire Healthcare NHS Foundation Trust Clinical Research

Our Clinical Research Team work with clinicians to promote, facilitate and deliver national studies within the Trust. The aim of the Team is to make it easier for NHS staff and service users to get involved in research. We are always on the lookout for individuals that have an interest in research and want to find out more about taking part in research projects.

The studies currently running within the Trust are listed below. All have had stringent checks and ethical approval from research committees across the country.

What is the purpose of the study?

The GLAD Study is a project set up to explore genetic risk factors in individuals who have suffered with or been diagnosed with depression and/or anxiety. The GLAD Study is a way for those who have experienced depression and/or anxiety to join the NIHR Mental Health BioResource, an NHS NIHR funded project which is part of the NIHR BioResource for Translational Research. The NIHR BioResource is a national initiative with the aim to collect genetic and clinical data from volunteers to build up a central library of information about people’s health. It offers you the chance to take part in ground-breaking research aimed at improving the lives of those not only with depression and anxiety, but other health conditions. 

What is involved?

Register on the GLAD website www.gladstudy.org.uk

Step 1: Giving consent to take part
The consent form includes a description of each of the types of activity you might be invited to take part in. It is up to you which ones you consent to.
We will request access to your medical records. Your data would only be provided to the GLAD and NIHR BioResource teams and, having been anonymised, to researchers approved by the GLAD Study, and/ or NIHR BioResource Steering Committee. We will also ask for your consent to be contacted in the future about other ongoing research studies that may be unrelated to anxiety and depression.
Step 2: Questionnaire data
We will ask you to complete some questions which will ask about your demographics (e.g. age, gender, and employment situation), emotional wellbeing, health and lifestyle, personality and experiences of depression and anxiety. This will take around 30-60 minutes to complete.
Step 3: Saliva sample
We will ask you to provide a saliva sample by spitting into a specially designed collection tube. This will be sent to you at home and you can send it back to us using a freepost envelope which we will provide.
We will extract DNA (i.e. genetic material) from this sample.
Samples will be stored without any of your personal details (e.g. name, date of birth, NHS number). 

Can I take part?

You can take part if you:

Are aged 16+
Are living in the UK
Have received treatment or experienced depression and/or anxiety now or in the past

Potential benefits of the study...

Once you are a member of the resource, you will be able to see information about further optional questionnaires, as well as a number of research studies that you are eligible to take part in. You may also be contacted about studies you may be eligible for that are not only related to anxiety and depression. We may assess your eligibility for these studies based on information you have provided (i.e. questionnaires), or information we have accessed from your medical records (i.e. diagnosis, treatment outcome) or samples (i.e genetic information). If you choose to do so, you can sign up to be a participant in up to 4 studies per year.
There may be no immediate benefit to you in terms of treatment, but you will contribute to knowledge about some of the causes of depression and/or anxiety. This knowledge may lead to better treatment guidelines and improve future care for patients.
The GLAD Study is an information resource for members as well as researchers. With this in mind, you will have access to pages dedicated to providing useful information to members.

Possible disadvantages
Some of the questionnaires ask about topics which some people might find sensitive, and about experiences of anxiety and/or depression. You do not have to complete any questions that you do not wish to.
Providing a saliva sample is a very low risk procedure but some people find it unpleasant.
Your participation is strictly confidential and the risk of identifiable information being accidentally disclosed is extremely low.

What next?

If you are interested in participating in this study you can join up online at www.gladstudy.org.uk or for further information please contact Rochelle Rhodes on 01332 623700 ext. 33266 or email DHCFT.Research@nhs.net

What is the purpose of the study?

The aim of this study is to collect information from adults on the autism spectrum, and update the information from time to time, to see how people’s lives change.

What is involved?

You will be asked to fill in a consent form and a questionnaire which will ask questions about your autism spectrum diagnosis and other information – like the types of support you receive, your employment opportunities, home, and information about aspects of your daily life. We will then contact you from time to time to ask you to give further information about your life.

Potential benefits of the study...

By taking part, you will help us with research that might lead to improvements in the services offered to people from the autism community. We will make sure our findings are shared with voluntary sector organisations, and government, to make sure we reach the people who can make these improvements.  No personal information will ever be released to researchers or anyone else. Any information that is published will always be anonymised.

What next?

If you are interested in participating in this study you can join up online at www.autismspectrum-uk.com or for further information please contact Graham Spencer on 01332 623700 ext. 33650 or email DHCFT.Research@nhs.net 

Click to download the Information Booklet 

Recruitment Temporarily Suspended

Poster: DPIM poster

Website:  http://www.ucl.ac.uk/molecular-psychiatry/bipolar-recruitment/about

If you are interested in participating in the study, further information and to check for eligibility please contact Gemma Elliott on 01332 623700 ext. 33474 or email us at DHCFT.Research@nhs.net.

Molecular Genetics of Adverse Drug Reactions

This is a DNA study, recruiting people who have experienced an Adverse Drug Reaction to Clozapine.

To find out more please read the Patient Information Leaflet or contact:        

Audrey Williamson on 01332 623700 ext. 33398 or email  DHCFT.Research@nhs.net  

Click to download the Patient Information Leaflet

What is the purpose of the study?

The ultimate aim of this research is to build a better understanding of the causes of Alzheimer’s Disease and in so doing, provide a platform for the development of targeted treatments and preventions.

Specifically the aim is to establish biomarkers which associate with the earliest stages of disease development, together with those which mark disease progression.

What is involved?

One-off interview with participant to establish symptoms of Alzheimer’s and blood sample, One-off interview with next of kin to obtain further detailed case history.

Criteria

If you are Caucasian and have been diagnosed with probable Alzheimer's before the age of 70 you can take part.

What next?

If you are interested in participating in the study, further information and to check for eligibility please contact Lisa Thomson, Clinical Studies Officer on 01332 623700 ext. 33266 or email us at  DHCFT.Research@nhs.net

http://medicine.cf.ac.uk/cngg/participate-research/alzheimers-disease-research-team/

What is the purpose of the study?

People with memory problems can struggle with everyday activities and may stop doing things they want to do. They are more prone to accidents. We have designed some therapy programmes to help maintain activity, independence, and balance. We need to try out different versions in a ‘feasibility study’, before we do a trial in 2018.

What is involved?

  • We will visit you at home to do an interview. We will ask about memory, general health, medicines you take, the activities you do and your motivation.

  • We will allocate you (at random) to one of three therapy programmes:

  • ­Assessment and advice with 1-3 visits from a therapist

  • ­Moderate-support with 11 therapist visits over for 3 months

  • ­A lot of support, with 50 therapist visits over 12 months

  • We expect that you will continue with the programme for at least a year

  • We will ask you to record activity, exercise, and falls, and we will telephone you monthly to ask some further questions and interview you again after a year

  • We will ask if you are continuing with the programme after 2 years

  • We may ask you, and a family member, to do an interview on what you thought about the programme

Criteria 

People taking part need to be 65 years or older and be known to Memory Assessment Service or JDR (Joint Dementia Research)

For further information please contact Gemma Harrison, Research Nurse on 01332 623700 ext. 33474 or email us at DHCFT.Research@nhs.net

Closed to Recruitment

What is the purpose of the study?

The primary objective of this study is to assess the safety and tolerability of intranasal esketamine in subjects with Treatment Resistant Depression, with special attention to the following:

  • Potential long term effects on cognitive function

  • Treatment-emergent adverse events (TEAEs), including TEAEs of special interest

  • Post dose effects on heart rate, blood pressure, respiratory rate and blood oxygen saturation

  • Potential effects on suicidal ideation/behaviour

Eligibility

To be considered for this study, you must be:

  • 65 years of age or older

  • Diagnosed with depression

  • Experiencing depression symptoms despite having taken two antidepressant medications in the past

  • Comfortable with using a nasal spray

  • Able to provide written consent to participate in the study

Recruitment to this study is now closed

What is the purpose of the study? 

It is known that people with mental health, neurodevelopmental and neurodegenerative disorders may have more problems with memory and concentration. It is not understood why this happens. The CAPMEM study would like to know if the autonomic nervous system works differently in people with mental health, neurodevelopmental and neurodegenerative disorders. Therefore people with and without (healthy volunteers) such disorders are being invited to take part in order to evaluate whether the autonomic nervous system is affected by the severity of the disorder or by medication use.

What is involved? 

The study involves completing a short questionnaire about nervous system symptoms such as dizziness. This takes approximately 10 minutes.

Eligibility  

As this study includes both people with a known mental health diagnosis and healthy volunteers the only inclusion criteria is ;age 16+ and capacity to consent.

What next?

To complete this short questionnaire online click here or for further information or a face to face interview please contact Debbie Risorto on 01332 623700 ext. 33580 or email DHCFT.Research@nhs.net

What is the purpose of the study?

A baby using their voice and reacting to voices is important for their speech and language development. This study will explore different brain patterns of babies whose mums have experienced mental illness. We want to examine how the brain processes voices and to understand how different factors may affect a child’s responses to sounds and voices.

What will happen to me if I take part?

The study involves assessments at 3 sessions when your baby is around 9 months, 12 months, and 18 months old. Before the first session we will shall ask you to complete a series of short questionnaires about your background (age, education, occupation, number of children etc.), as well as your own childhood experiences and how you are feeling in your mood. We will ask you to provide us access to your medical records so that we can accurately document your post-natal mental health illness and treatments.  
We will ask you for access to your child’s personal health record or ‘Little Red Book’ so that we can record your infant’s growth charts and medical history. 
 
What will happen to my baby if he/she takes part?


We will ask you to play with your child for about 10 minutes while we video record this activity and we shall provide toys and a play mat for you to use. The video recordings are used to measure the interaction between you and your baby. These videos will not be shown publicly or images used in publications and are for research purposes only. 
Finally, we would then like to carry out with your baby a very simple and very safe assessment called functional near infrared spectroscopy (fNIRS). This will allow us to record your baby’s brain responses to sounds. We will ask you to sit your baby on your lap and we will place a soft cap on your baby’s head. Your baby will listen to some sounds (human voices, non-human sounds) and watch some video clips (cartoons) while his/ her brain responses will be quietly collected. The cap placed on your baby’s head is made from soft material and is positioned to be as comfortable as possible on your infant’s head. 
 
During the fNIRS assessment we will also video record your baby so that we can later remove the effects of any head movement on the data we collect. This video will not be shown publicly or the images used in publications, it is for research purposes only. All together this first session will take about an hour and a half of your time but we can take regular breaks as required for you or your baby. Or if it is more suitable we can split this session in to two parts.

The second session which will be  about 3 months after the first, is much shorter and will only require us to carry out the fNIRS brain imaging assessment exactly as before, together with a short developmental assessment for your baby. This should only take one hour.

The final session will follow around 6 months after the second, and will only require us to carry out the fNIRS brain imaging assessment, together with the developmental assessment for your baby. At this final session we will go through a short interview with you to discuss how you felt about taking part in this study. This should only take one hour.

Can I take part?

Inclusion criteria:
Mum’s must have capacity to consent to study
Have proficiency in English
Have a baby 10 months or younger

Exclusion criteria:
Primary diagnosis of substance/alcohol abuse
Primary diagnosis of anorexia/bulimia nervosa
Primary diagnosis of personality disorders
Infants with congenital malformations, severe chronic illnesses, or developmental disorders

Potential benefits of the study...

By taking part in this study, you will help us understand how a baby’s brain development may be influenced by different factors. Unfortunately, we are not able to provide individual information on brain activation because scans will be averaged across all participants for research purposes


What next?

If you are interested in participating in the study, further information and to check for eligibility please contact Andy Dingwall on 01332 623700 ext. 33398 or email us at DHCFT.Research@nhs.net

What is the purpose of the study?

The study aims to understand if some cases of psychosis are caused by immune system problems in some people. The immune system normally controls our ability to fight infection. If the immune system goes wrong it may cause diseases called ‘autoimmune’ diseases. We can diagnose some of these immune diseases using blood tests.  

Inclusion Criteria

  • Male or Female, aged 18-70

  • Diagnosis of first episode psychotic illness, or relapse after a period of wellness

  • Symptoms for less than 2 years

Exclusion Criteria

The participant may not enter the study if ANY of the following apply: 
Any other neurological disorders including multiple sclerosis, epilepsy, cerebrovascular disease, hydrocephalus, traumatic brain injury, meningo-encephalitis, systemic lupus erythematosus, CNS vasculitis or primary drug induced psychosis

What will I have to do?

You will spend 15 minutes of your time with a member of the research team discussing your illness. You will have a sample of blood taken. We will pay you £10 to compensate for the time and inconvenience

If you are interested in participating in the study, further information and to check for eligibility please contact Graham Spencer on 01332 623700 ext. 33650 or email DHCFT.Research@nhs.net

ENRICH is an initiative set up by the National Institute of Health Research (NIHR) to encourage more research in care homes. The Research Ready Care Home Network aims to bring care home staff, residents and researchers together in order to facilitate the design and delivery of research with the hope of improving quality of life, treatments and care for older people living in care homes.

If you are interested in finding out more information about the benefits of joining your local network in Derbyshire please contact Natalie Startin at DHCFT.Research@nhs.net  or on 01332 623700 Ext. 33489.

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.

Click here to read the full report

Click here to view in NIHR Journals Library

 

LABILE - The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial

Click here to read the full report

Click to view in The American Journal of Psychiatry

If any of the studies currently running are of interest to you and you think you may be eligible, you can register your interest by completing the Expressions of Interest form. One of our Research Team will make contact; you are under no obligation to take part and can pull out of the study at any stage.

Alternatively you can contact us on:

Tel: 01332 623700 ext 33407
Email:  DHCFT.Research@nhs.net
Text “Interested” to 07825 935177

We look forward to hearing from you

  • Keeley Marriott, Clinical Research Assistant
  • Rochelle Rhodes, Senior Clinical Research Assistant
  • Lisa Thomson, Clinical Researcher
  • Gemma Harrison, Research Nurse
  • Graham Spencer, Research Nurse
  • Audrey Williamson, Research Nurse
  • Caroline Cheetham, Research Nurse
  • Andy Dingwall, Research Nurse
  • Debbie Risorto, Occupational Therapist
Other ways to get involved... 
What is a Research Ambassador and what are their aims?

A Research Ambassador is a volunteer who promotes research from their perspective. They are enthusiastic about health research and ae willing to explain more about research and participation to patients, staff and the public.
A Research Ambassador aims:
• To help service users to gain easier access to research
• Help to develop a research culture within our Trust and to embed and take research forward
• Bridge the gap between patients, staff and the research department
• To give personal experience and views


Who can be a Research Ambassador?

We are always looking for Research Ambassadors - they can be patient, carer or staff . They should have experience of taking part in research and be passionate!! These roles are flexible and will develop with each individual Research Ambassadors strengths


What sort of things does a Research Ambassador do?

• Take part in the Trust induction for new staff
• Promote research projects
• Share personal experience of taking part in research and reassure potential participants that may have concerns
• Speak to staff about the importance of offering research to patients
• Talk to friends, family, patients, staff and the public about research
• Take part in events including International Clinical Trials Day.
• Support local engagement teams to raise awareness of opportunities to participate in research studies

To learn more about becoming a Research Ambassador please email: keeleymarriott@nhs.net or call 01332 62377 ext 33407 for an informal chat
 

 

Performance

Performance information on the initiation and delivery of clinical research

The Government wishes to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivering clinical research. The aim is to increase the number of patients who have the opportunity to participate in research and to enhance the nation’s attractiveness as a host for research. Providers of NHS services are required to publish information on recruitment to clinical trials and delivery to time and to target for commercial clinical trials. 

Useful links:
Join Dementia Research
Hide this section
Show accessibility tools